Literature DB >> 25680409

Hedgehog pathway aberrations and gastric cancer; evaluation of prognostic impact and exploration of therapeutic potentials.

Omar Abdel-Rahman1.   

Abstract

Gastric cancer is an important cause for mortality and morbidity worldwide; it lies in the fourt rank as a cause of cancer-related death in males and in the fifth rank of cancer-related death in women. The prognosis of advanced/metastatic gastric cancer cases looks poor with the majority of available therapeutics. Thus, novel therapeutic strategies in this setting have been considered a priority for leading cooperative oncology groups. Hedgehog(Hh) pathway aberrations have sparked particular interest as prognostic markers with data from multiple studies showing consistent evidence of a poor prognostic value of Gli over expression in gastric cancer while on the other hand the prognostic significance of Hh protein over expression (particularly SHH) was not consistent among different studies. This review article revises the prognostic and potential therapeutic opportunities in the targeting of hedgehog pathway in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25680409     DOI: 10.1007/s13277-015-3216-6

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  33 in total

1.  Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb.

Authors:  B Wang; J F Fallon; P A Beachy
Journal:  Cell       Date:  2000-02-18       Impact factor: 41.582

2.  Suppression of growth and migration by blocking the Hedgehog signaling pathway in gastric cancer cells.

Authors:  Runwei Yan; Xiang Peng; Xiaogang Yuan; Dengliang Huang; Jiang Chen; Quqin Lu; Nonghua Lv; Shiwen Luo
Journal:  Cell Oncol (Dordr)       Date:  2013-09-13       Impact factor: 6.730

Review 3.  Targeting the hepatocyte growth factor/mesenchymal epithelial transition pathway in gastric cancer: biological rationale and clinical applications.

Authors:  Omar Abdel-Rahman
Journal:  Expert Rev Anticancer Ther       Date:  2014-10-29       Impact factor: 4.512

4.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

5.  Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer.

Authors:  Young A Yoo; Myoung Hee Kang; Hyun Joo Lee; Baek-hui Kim; Jong Kuk Park; Hyun Koo Kim; Jun Suk Kim; Sang Cheul Oh
Journal:  Cancer Res       Date:  2011-10-05       Impact factor: 12.701

6.  A phase II, randomized, placebo-controlled study of vismodegib as maintenance therapy in patients with ovarian cancer in second or third complete remission.

Authors:  Stanley B Kaye; Louis Fehrenbacher; Robert Holloway; Amnon Amit; Beth Karlan; Brian Slomovitz; Paul Sabbatini; Ling Fu; Robert L Yauch; Ilsung Chang; Josina C Reddy
Journal:  Clin Cancer Res       Date:  2012-10-02       Impact factor: 12.531

7.  Altered expression of PTCH and HHIP in gastric cancer through their gene promoter methylation: novel targets for gastric cancer.

Authors:  Yu Song; Ye Tian; Yun Zuo; Jian-Cheng Tu; Yu-Fang Feng; Chen-Jiang Qu
Journal:  Mol Med Rep       Date:  2013-02-21       Impact factor: 2.952

8.  CD44 expression denotes a subpopulation of gastric cancer cells in which Hedgehog signaling promotes chemotherapy resistance.

Authors:  Changhwan Yoon; Do Joong Park; Benjamin Schmidt; Nicholas J Thomas; Hae-June Lee; Teresa S Kim; Yelena Y Janjigian; Deirdre J Cohen; Sam S Yoon
Journal:  Clin Cancer Res       Date:  2014-06-19       Impact factor: 12.531

Review 9.  Targeted therapy for advanced esophagogastric adenocarcinoma.

Authors:  S Kordes; A Cats; S L Meijer; H W M van Laarhoven
Journal:  Crit Rev Oncol Hematol       Date:  2013-10-12       Impact factor: 6.312

10.  Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research.

Authors:  Rebecca C Fitzgerald; Richard Hardwick; David Huntsman; Fatima Carneiro; Parry Guilford; Vanessa Blair; Daniel C Chung; Jeff Norton; Krishnadath Ragunath; J Han Van Krieken; Sarah Dwerryhouse; Carlos Caldas
Journal:  J Med Genet       Date:  2010-07       Impact factor: 6.318

View more
  14 in total

1.  The relationship between five non-synonymous polymorphisms within three XRCC genes and gastric cancer risk in a Han Chinese population.

Authors:  Huansong Gong; He Li; Jing Zou; Jia Mi; Fang Liu; Dan Wang; Dong Yan; Bin Wang; Shuping Zhang; Geng Tian
Journal:  Tumour Biol       Date:  2015-11-21

2.  Protein arginine methyltransferase 1 promoted the growth and migration of cancer cells in esophageal squamous cell carcinoma.

Authors:  Weizheng Zhou; Hui Yue; Chunguang Li; Hezhong Chen; Yang Yuan
Journal:  Tumour Biol       Date:  2015-09-22

Review 3.  Targeted therapies in gastric cancer treatment: where we are and where we are going.

Authors:  Gianluca Tomasello; Michele Ghidini; Wanda Liguigli; Margherita Ratti; Laura Toppo; Rodolfo Passalacqua
Journal:  Invest New Drugs       Date:  2016-02-12       Impact factor: 3.850

Review 4.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

5.  Identification and validation of a Hedgehog pathway-based 3-gene prognostic signature for gastric cancers.

Authors:  Jianbing Wu; Xi Wang; Wei Lu
Journal:  Oncol Lett       Date:  2018-06-11       Impact factor: 2.967

6.  Nuclear Gli1 expression is associated with pathological complete response and event-free survival in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant therapy.

Authors:  Shiwei Liu; Xuening Duan; Ling Xu; Jingming Ye; Yuanjia Cheng; Qian Liu; Hong Zhang; Shuang Zhang; Sainan Zhu; Ting Li; Yinhua Liu
Journal:  Tumour Biol       Date:  2015-11-02

Review 7.  Pathogenic roles of alterations in vitamin D and vitamin D receptor in gastric tumorigenesis.

Authors:  Chao Du; Shiming Yang; Xiaoyan Zhao; Hui Dong
Journal:  Oncotarget       Date:  2017-04-25

Review 8.  Hedgehog Signaling Links Chronic Inflammation to Gastric Cancer Precursor Lesions.

Authors:  Juanita L Merchant; Lin Ding
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-01-16

9.  Itraconazole induces apoptosis and cell cycle arrest via inhibiting Hedgehog signaling in gastric cancer cells.

Authors:  Qiang Hu; Yi-Chao Hou; Jiao Huang; Jing-Yuan Fang; Hua Xiong
Journal:  J Exp Clin Cancer Res       Date:  2017-04-11

Review 10.  Critical evaluation of ramucirumab in the treatment of advanced gastric and gastroesophageal cancers.

Authors:  Hesham ElHalawani; Omar Abdel-Rahman
Journal:  Ther Clin Risk Manag       Date:  2015-07-28       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.